Therefore, we demonstrated that MYC promotes PARP1-mediated repair in MM and that anti-proliferative effects exerted by PARP inhibition are mainly observed in MYC-proficient MM cells, thus identifying a novel potential predictive biomarker of PARPis’ sensitivity in MM. This evidence concerns the gene PARP1 and Miyoshi myopathy.